Safety and immunogenicity of whole-virus, alum-adjuvanted whole-virus, virosomal, and whole-virus intradermal influenza A/H9N2 vaccine formulations. (Q30381301)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Safety and immunogenicity of whole-virus, alum-adjuvanted whole-virus, virosomal, and whole-virus intradermal influenza A/H9N2 vaccine formulations.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799843%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Safety and immunogenicity of whole-virus, alum-adjuvanted whole-virus, virosomal, and whole-virus intradermal influenza A/H9N2 vaccine formulations (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799843%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799843%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Karl G Nicholson

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799843%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Catherine I Thompson

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799843%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Jaco M Klap

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799843%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

John M Wood

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799843%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Robert W Newman

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799843%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Robert Mischler

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799843%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Maria C Zambon

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799843%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Iain Stephenson

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799843%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

language of work or name

0 references

publication date

30 September 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799843%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799843%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799843%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799843%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

171-178

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799843%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Antigenic and genetic characterization of H9N2 swine influenza viruses in China.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.103

7 January 2021

Continuing evolution of H9N2 influenza viruses in Southeastern China.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.103

7 January 2021

H9N2 influenza A viruses from poultry in Asia have human virus-like receptor specificity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.103

7 January 2021

Characterization of a human H9N2 influenza virus isolated in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.103

7 January 2021

Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.103

7 January 2021

Cocirculation of avian H9N2 and contemporary "human" H3N2 influenza A viruses in pigs in southeastern China: potential for genetic reassortment?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.103

7 January 2021

Human infection with influenza H9N2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.103

7 January 2021

Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.103

7 January 2021

Antibodies against H5 and H9 avian influenza among poultry workers in China

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.103

7 January 2021

Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.103

7 January 2021

Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.103

7 January 2021

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.103

7 January 2021

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.103

7 January 2021

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.103

7 January 2021

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.103

7 January 2021

Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.103

7 January 2021

A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.103

7 January 2021

Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.103

7 January 2021

[Subcutaneous and intradermal vaccination with Asian influenza vaccine]

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.103

7 January 2021

Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.103

7 January 2021

Molecular analysis of an outbreak of influenza in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.103

7 January 2021

Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: an international collaborative study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.103

7 January 2021

Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.103

7 January 2021

Immunogenicity of new virosome influenza vaccine in elderly people

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.103

7 January 2021

Determinants of immunity to influenza infection in man

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.103

7 January 2021

Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutinin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.103

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.09.103

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799843%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19799843%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30381301&oldid=1549968525"